GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 94 filers reported holding GOSSAMER BIO INC in Q4 2019. The put-call ratio across all filers is 13.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,156,000 | +349.3% | 513,793 | +214.0% | 0.00% | +100.0% |
| Q2 2022 | $1,370,000 | -23.2% | 163,626 | -19.8% | 0.00% | 0.0% |
| Q1 2022 | $1,784,000 | -16.1% | 203,936 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $2,127,000 | -8.9% | 206,954 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $2,335,000 | +25.9% | 221,959 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,854,000 | -78.8% | 228,347 | -75.8% | 0.00% | -66.7% |
| Q1 2021 | $8,735,000 | +25.8% | 944,294 | +31.5% | 0.00% | +50.0% |
| Q4 2020 | $6,945,000 | -1.5% | 718,216 | +26.4% | 0.00% | -33.3% |
| Q3 2020 | $7,054,000 | +188.2% | 568,420 | +201.9% | 0.00% | +200.0% |
| Q2 2020 | $2,448,000 | +24.6% | 188,290 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,965,000 | -29.5% | 193,621 | +8.6% | 0.00% | 0.0% |
| Q4 2019 | $2,786,000 | -2.8% | 178,240 | +4.4% | 0.00% | 0.0% |
| Q3 2019 | $2,866,000 | +33.1% | 170,693 | +75.8% | 0.00% | 0.0% |
| Q2 2019 | $2,153,000 | – | 97,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |